PEG-interferon after interferon alfa-2b for hypereosinophilic syndrome

被引：3
|
作者：
Butterfield, J. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 119卷 / 01期
关键词：
D O I：
10.1016/j.jaci.2006.12.241
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
874
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [1] Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin
    Pavan, M. H. P.
    Velho, P. E. N. F.
    Vigani, A. G.
    Goncalves, F. L.
    Aoki, F. H.
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03): : 383 - 384
  • [2] PEG-interferon alfa-2b for acute hepatitis C: A review
    Palumbo, Emilio
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (08) : 839 - 843
  • [3] Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b
    Lyrdal, David
    Stierner, Ulrika
    Lundstam, Sven
    [J]. ACTA ONCOLOGICA, 2009, 48 (06) : 901 - 908
  • [4] Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4.
    Esmat, G
    Abouzied, AM
    Abdel-Aziz, F
    Mohamed, MK
    Abdel-Hamid, M
    El Raziky, MS
    Ismail, SA
    Zalata, KR
    Mikhail, NN
    Fix, A
    Strickland, T
    Sjogren, MH
    [J]. HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [5] Peg-interferon alfa-2b and Ribavirin for the treatment of genotype 1 hepatitis C recurrence after liver transplantation
    Lodato, F.
    Berardi, S.
    Gramenzi, A.
    Mazzella, G.
    Lenzi, M.
    Morelli, M. C.
    Tame, Mr.
    Piscaglia, F.
    Andreone, P.
    Ballardini, G.
    Bernardi, M.
    Bianchi, F. B.
    Biselli, M.
    Bolondi, L.
    Cescon, M.
    Colecchia, A.
    D'Errico, A.
    Del Gaudio, M.
    Ercolani, G.
    Grazi, G. L.
    Grigioni, W.
    Lorenzini, S.
    Pinna, A. D.
    Ravaioli, M.
    Roda, E.
    Sama, C.
    Vivarelli, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A36 - A36
  • [6] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 79 - 79
  • [7] PEG-Interferon alfa-2b plus Ribavirin-Behandlung bei chronischer Hepatitis C
    [J]. Monatsschrift Kinderheilkunde, 2005, 153 (12) : 1192 - 1193
  • [8] Treatment with Peg-interferon alfa-2b in patients affected by acute hepatitis C: A pilot study
    Scotto, G
    Palumbo, E
    Fazio, V
    Cibelli, DC
    Saracino, A
    Angarano, G
    [J]. HEPATOLOGY, 2004, 40 (04) : 331A - 331A
  • [9] Treatment with Peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia
    Saadoun, D
    Cacoub, P
    [J]. JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 737 - 737
  • [10] Pegylated interferon alfa-2b (PEG-Intron) monotherapy is superior to interferon alfa-2b (Intron A) for the treatment of chronic hepatitis C
    Trepo, C
    Lindsay, K
    Niederau, C
    Shiffman, M
    Gordon, S
    Hoefs, J
    Schiff, E
    Marcellin, P
    Bacon, B
    Fang, J
    Garaud, J
    Albrecht, J
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 29 - 29
12345